Northwest Biotherapeutics (NWBO) Depreciation and Depletion (2014 - 2026)
Northwest Biotherapeutics' (NWBO) quarterly Depreciation and Depletion came in at $600000.0 in Q1 2026, up 50.0% year-on-year from $400000.0 in Q1 2025, and up 50.0% quarter-over-quarter from $400000.0 in Q1 2025.
Northwest Biotherapeutics (NWBO) Depreciation and Depletion (2014 - 2026) Analysis & Trends
Northwest Biotherapeutics' Depreciation and Depletion history runs 12 years deep, the most recent figure standing at $600000.0 for Q1 2026.
- On a quarterly basis, Depreciation and Depletion rose 50.0% year-over-year to $600000.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 11.76% increase from a year earlier, with the FY2025 full-year figure at $1.9 million, up 11.76% from the prior year.
- Depreciation and Depletion rose to $600000.0 in Q1 2026 per NWBO's latest filing, from $400000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $600000.0 in Q1 2026 and bottomed at $100000.0 in Q1 2022.
- The 5-year median for Depreciation and Depletion is $400000.0 (2022), against an average of $391666.7.
- Biggest YoY gain for Depreciation and Depletion was 200.0% in 2023; the steepest drop was 20.0% in 2023.
- Year by year, Depreciation and Depletion stood at $400000.0 in 2022, then changed by 0.0% to $400000.0 in 2023, then grew by 25.0% to $500000.0 in 2024, then dropped by 20.0% to $400000.0 in 2025, then surged by 50.0% to $600000.0 in 2026.
- Per Business Quant, the three latest NWBO Depreciation and Depletion figures stand at $600000.0 (Q1 2026), $400000.0 (Q1 2025), and $500000.0 (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Northwest Biotherapeutics | 253,653.43 | -1.53 Mn | - | 600,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 600,000.00 |
| Mar 31, 2026 | 600,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Sep 30, 2023 | 400,000.00 |
| Sep 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 400,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | 400,000.00 |
| Dec 31, 2022 | 400,000.00 |
| Sep 30, 2022 | 300,000.00 |
| Sep 30, 2022 | 300,000.00 |